Significance of CD163-positive macrophages in proliferative glomerulonephritis

American Journal of the Medical Sciences

Volumn 350, Issue 5, 2015, Pages 387-392

  Li, Jun ^a   Liu, Chang Hua ^a   Xu, Dao Liang ^a   Gao, Bo ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Acute kidney injury; CD163; Macrophage; Proliferative glomerulonephritis

Indexed keywords

CD163 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LCN2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LIPOCALIN; ONCOPROTEIN; SCAVENGER RECEPTOR;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIGEN EXPRESSION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOPATHOGENESIS; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY PARENCHYMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MINIMAL CHANGE DISEASE; PAUCI IMMUNE NECROTIZING GLOMERULONEPHRITIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN URINE LEVEL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; TISSUE LEVEL; YOUNG ADULT; ADOLESCENT; AGED; BLOOD; CHINA; GLOMERULONEPHRITIS; IMMUNOLOGY; KIDNEY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT ACUITY; STATISTICS; URINE;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHINA; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPOCALINS; MACROPHAGES; MALE; MIDDLE AGED; PATIENT ACUITY; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; STATISTICS AS TOPIC;

EID: 84946542731     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000569     Document Type: Article

References (23)

1. Yang N, Isbel NM, Nikolic-Paterson DJ, et al. Local macrophage proliferation in human glomerulonephritis. Kidney Int 1998;54: 143-51.
2. Alagesan S, Griffin MD. Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor. Kidney Int 2014;85:730-3.
3. Furuhashi K, Tsuboi N, Shimizu A, et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immuno-regulatory macrophages. J Am Soc Nephrol 2013;24:587-603.
4. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008;118:3522-30.
5. Anders HJ, Ryu M. Renal microenvironments and macrophage phe-notypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011;80:915-25.
6. Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
7. Stout RD, Jiang C, Matta B, et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmen-tal influences. J Immunol 2005;175:342-9.
8. Han Y, Ma FY, Tesch GH, et al. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Am J Physiol Ren Physiol 2013;304:F1043-53.
9. Zhao L, David MZ, Hyjek E, et al. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Clin J Am Soc Nephrol 2015;10:54-62.
10. Nakayama W, Jinnin M, Makino K, et al. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus. Eur J Dermatol 2012;22:512-7.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
12. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-30.
13. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1-11.
14. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell (temporal) arteritis. Arthritis Rheum 1990;33:1122-8.
15. Gutiérrez E, Egido J, Rubio-Navarro A, et al. Oxidative stress, mac-rophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 2012;121:42-53.
16. Martín Cleary C, Moreno JA, Fernández B, et al. Glomerular hae-maturia, renal interstitial haemorrhage and acute kidney injury. Nephrol Dial Transpl 2010;25:4103-6.
17. Ballarín J, Arce Y, Torra Balcells R, et al. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transpl 2011;26:3408-11.
18. Vanmassenhove J, Vanholder R, Nagler E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transpl 2013;28:254-73.
19. Hammad A, Mosaad Y, Elhanbly S, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus 2013;22:486-91.
20. Lieberthal JG, Cuthbertson D, Carette S, et al. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 2013;40:674-83.
21. Kushiyama T, Oda T, Yamada M, et al. Alteration in the phenotype of macrophages in the repair of renal interstitial fibrosis in mice. Nephrology (Carlton) 2011;16:522-35.
22. Huen SC, Huynh L, Marlier A, et al. Gm-csf Promotes macrophage alternative activation after renal Ischemia/Reperfusion injury. J Am Soc Nephrol 2015;26:1334-45.
23. Ikezumi Y, Suzuki T, Karasawa T, et al. Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis. Am J Nephrol 2010;31:273-82.